Machine Perfusion in High vs Low/Mid-volume Liver Trans... | Clinical Trial | StuddyBuddy@endsection Machine Perfusion in High vs Low/Mid-volume Liver Transplant Centers: a Multicentre Survey
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05662969

Machine Perfusion in High vs Low/Mid-volume Liver Transplant Centers: a Multicentre Survey

Conditions: Organ Preservation Solution

Sex: All
Enrollment: 67
Sponsor: Roberta Angelico

Location: Italy

Summary

Introduction: Machine perfusion (MP) was developed to expand the available donor pool and to improve liver transplantation outcomes. Despite optimal results in clinical trials, MP benefit outside of clinical experimentation in unknown. Low/mid volume centres (L/MVCs) may face logistical/economical difficulties that may in turn hamper optimal MP results.Methods: An Online 22-item survey on the use of machine perfusion for liver transplantation outside of clinical trials, was distributed to worldwide LT centres representatives. Variables of interest included MP logistics, MP technicalities, MP results, post-MP LT results. Responding centres were grouped into high volume centre (HVCs)(defined as >60 LTs per year in 2019) and L/MVCs. Results from HVCs vs L/MVCs were compared.

Eligibility Criteria

Inclusion Criteria:LT centres that use MPLT centres which perform LT before pandemic time (before 2019 included)LT centres which perform LT from cadaveric donors and living donorsExclusion Criteria:LT centres that not use MPLT centres that use MP but on clinical trials

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05662969). StuddyBuddy aggregates publicly available trial information.